Coverage of high-potential mid-market firms in Poland


Neuca pharma expects PLN 115 mln net profit in 2017 ex one-offs


Listed pharmaceuticals distributor Neuca expects to post a PLN 115 mln net profit in 2017 excluding one-offs, Neuca said in a market filing.

The guidance is based on assumption of 4-5% growth of the wholesale pharmaceuticals market, the firm said.

Neuca will verify the viability of the guidance in quarterly periods, the firm said.


Analysts' forecasts collected by PAP so for point to PLN 118.25 mln net profit for Neuca in 2017.


In 2016, Neuca posted PLN 111.1 mln net profit, meeting its guidance for PLN 110 mln net take.


Comments : 0

Add comment

The published comments are private opinions of the users. Biznespolska Media Sp. z o.o. is not responsible for their content. Intelligent and insightful comments most appreciated.

Other News

Photo of the week

Photo of the week

Tobias Solorz the CEO of Cyfrowy Polsat SA spearheads the company's improved rating, from "stable" to "positive" (BB+) by S&P Global Ratings (formerly Standard&Poor's Rating Services) ("S&P") following a stellar performance and robust deleveraging capacity in 2017-2018


WSE Indices

WIG20 2382,78 -
WIG 61644,56 -0,14 % 17:15
sWIG80 16300,66 +0,45 % 17:15
NCIndex 329,99 +0,76 % 17:15

WSE Companies

Top 5 Gainers

BUDOPOL0,06+20,00 %
KREZUS1,49+10,37 %
SADOVAYA GROUP0,32+10,34 %
SECO WARWICK24,20+10,00 %
COAL ENERGY1,03+8,42 %

Top 5 Losers

FON0,42-22,22 %
HAWE0,27-15,62 %
DELKO10,65-10,50 %
ZASTAL0,27-10,00 %